Compare IMMX & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMMX | UNTY |
|---|---|---|
| Founded | 2014 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 629.3M | 539.4M |
| IPO Year | 2021 | 2014 |
| Metric | IMMX | UNTY |
|---|---|---|
| Price | $9.76 | $58.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $19.20 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 1.5M | 55.5K |
| Earning Date | 05-08-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | N/A | ★ 39.66 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.14 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | ★ N/A | $41.39 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.94 | $44.34 |
| 52 Week High | $11.61 | $58.40 |
| Indicator | IMMX | UNTY |
|---|---|---|
| Relative Strength Index (RSI) | 59.36 | 66.19 |
| Support Level | $7.99 | $50.20 |
| Resistance Level | $9.77 | N/A |
| Average True Range (ATR) | 0.74 | 1.49 |
| MACD | 0.20 | 0.28 |
| Stochastic Oscillator | 73.16 | 68.93 |
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.